Covered recipient · General Payments record
SHANE R KANNARR
Eye and Vision Services Providers Optometrist
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2021 · Entire year
$63,223.61
151 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2021 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,943.75 | 28 |
| Consulting Fee | $25,652.50 | 12 |
| Travel and Lodging | $3,269.74 | 23 |
| Food and Beverage | $3,157.62 | 87 |
| Honoraria | $1,200.00 | 1 |
By paying entity
PY2021 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Allergan, Inc. | $44,679.95 | 89 |
| Johnson & Johnson Vision Care, Inc. | $15,628.80 | 28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,255.88 | 4 |
| Kala Pharmaceuticals, Inc. | $901.82 | 8 |
| Novartis Pharmaceuticals Corporation | $369.51 | 9 |
| Sight Sciences, Inc. | $213.03 | 3 |
| Bausch & Lomb, a division of Bausch Health US, LLC | $97.05 | 6 |
| Alcon Vision LLC | $77.57 | 4 |
Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
SHANE R KANNARR
NPI 1891772489 · CMS profile ID 40742
Eye and Vision Services Providers / Optometrist
PITTSBURG, KS
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- SHANE R KANNARR, NPI 1891772489, CMS profile ID 40742. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
- APA 7
- IndustryPayments. (2026). SHANE R KANNARR, NPI 1891772489, CMS profile ID 40742. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
- Bluebook
- SHANE R KANNARR, NPI 1891772489, CMS profile ID 40742, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 151 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1891772489?year=2021&recipient=provider&page=3#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2021
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30
151 matching records · $63,223.61 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 101–150 of 151.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Allergan, Inc. | $68.85 | 06/25/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826671 | CMS |
| Allergan, Inc. | $36.00 | 06/25/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826673 | CMS |
| Allergan, Inc. | $1,125.00 | 06/25/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826675 | CMS |
| Allergan, Inc. | $19.20 | 06/24/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826667 | CMS |
| Allergan, Inc. | $800.00 | 06/24/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826669 | CMS |
| Kala Pharmaceuticals, Inc. | $26.80 | 06/24/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 815672313 | CMS |
| Sight Sciences, Inc. | $73.41 | 06/24/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851134577 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $12.85 | 06/09/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851226493 | CMS |
| Johnson & Johnson Vision Care, Inc. | $17.00 | 05/27/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 787840583 | CMS |
| Allergan, Inc. | $800.00 | 05/12/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826665 | CMS |
| Allergan, Inc. | $800.00 | 05/05/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826663 | CMS |
| Allergan, Inc. | $29.98 | 05/04/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826659 | CMS |
| Allergan, Inc. | $1,125.00 | 05/04/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826661 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $16.06 | 05/04/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851226487 | CMS |
| Novartis Pharmaceuticals Corporation | $34.40 | 05/03/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 812740983 | CMS |
| Allergan, Inc. | $36.60 | 05/01/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826657 | CMS |
| Allergan, Inc. | $29.17 | 04/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826647 | CMS |
| Allergan, Inc. | $1,350.00 | 04/30/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826649 | CMS |
| Allergan, Inc. | $16.97 | 04/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826651 | CMS |
| Allergan, Inc. | $67.00 | 04/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826653 | CMS |
| Allergan, Inc. | $1,125.00 | 04/30/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826655 | CMS |
| Johnson & Johnson Vision Care, Inc. | $2,000.00 | 04/30/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 989021745 | CMS |
| Novartis Pharmaceuticals Corporation | $6.99 | 04/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 812740981 | CMS |
| Novartis Pharmaceuticals Corporation | $88.73 | 04/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 812740985 | CMS |
| Sight Sciences, Inc. | $25.60 | 04/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851134581 | CMS |
| Allergan, Inc. | $38.81 | 04/29/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826643 | CMS |
| Allergan, Inc. | $42.05 | 04/29/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826645 | CMS |
| Allergan, Inc. | $7.33 | 04/28/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826639 | CMS |
| Allergan, Inc. | $800.00 | 04/28/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826641 | CMS |
| Johnson & Johnson Vision Care, Inc. | $500.00 | 04/23/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 989021747 | CMS |
| Allergan, Inc. | $1,200.00 | 04/17/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826635 | CMS |
| Allergan, Inc. | $29.98 | 04/17/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826637 | CMS |
| Allergan, Inc. | $6.08 | 04/09/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826633 | CMS |
| Bausch & Lomb, a division of Bausch Health US, LLC | $15.17 | 04/07/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851226491 | CMS |
| Johnson & Johnson Vision Care, Inc. | $225.00 | 03/26/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 787840557 | CMS |
| Alcon Vision LLC | $17.27 | 03/19/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 797721907 | CMS |
| Johnson & Johnson Vision Care, Inc. | $2,000.00 | 03/19/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 989021743 | CMS |
| Allergan, Inc. | $800.00 | 03/17/2021 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826631 | CMS |
| Allergan, Inc. | $29.98 | 03/15/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826629 | CMS |
| Alcon Vision LLC | $20.13 | 03/09/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 797721917 | CMS |
| Allergan, Inc. | $24.69 | 02/27/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826625 | CMS |
| Allergan, Inc. | $1,575.00 | 02/27/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826627 | CMS |
| Allergan, Inc. | $148.96 | 02/13/2021 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826623 | CMS |
| Johnson & Johnson Vision Care, Inc. | $17.68 | 02/02/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 787840565 | CMS |
| Allergan, Inc. | $1,687.50 | 01/30/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826619 | CMS |
| Allergan, Inc. | $29.43 | 01/30/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826621 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.31 | 01/19/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 851929411 | CMS |
| Allergan, Inc. | $2,025.00 | 01/01/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826611 | CMS |
| Allergan, Inc. | $5,962.50 | 01/01/2021 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826613 | CMS |
| Allergan, Inc. | $27.95 | 01/01/2021 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 792826615 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $690,464.98 | 187 |
| PY2024 | Principal investigator | $335,075.37 | 61 |
| PY2023 | Recipient | $51,030.00 | 2 |
| PY2023 | Principal investigator | $353,478.19 | 37 |
| PY2022 | Principal investigator | $608,075.06 | 219 |
| PY2021 | Recipient | $22,512.50 | 1 |
| PY2021 | Principal investigator | $606,083.65 | 306 |
| PY2020 | Principal investigator | $582,322.33 | 417 |
| PY2019 | Recipient | $2,500.00 | 1 |
| PY2019 | Principal investigator | $689,191.82 | 213 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
187 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $27,406.00 | 12/23/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of investigational contact lenses | No dispute reported | 06/30/2026 | 1174888453 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $11,850.00 | 12/23/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Evaluating myopia progression after discontinuation of a soft contact lens for myopia control. | No dispute reported | 06/30/2026 | 1174888538 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $1,000.00 | 12/18/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of approved contact lenses | No dispute reported | 06/30/2026 | 1174888551 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $8,209.00 | 12/16/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of investigational contact lenses | No dispute reported | 06/30/2026 | 1174888430 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $2,980.00 | 12/16/2025 | Non-covered Recipient Entity Kannar Eye Center | Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) | No dispute reported | 06/30/2026 | 1238522792 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $10,936.00 | 12/12/2025 | Non-covered Recipient Entity Kannar Eye Center | OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) | No dispute reported | 06/30/2026 | 1238522802 |
| Principal investigator 1 | CooperVision Inc. | $11,880.00 | 11/25/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | CV-20-02 | No dispute reported | 06/30/2026 | 1243636048 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $14,458.40 | 11/17/2025 | Non-covered Recipient Entity Kannarr Eye Care, LLC | A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness | No dispute reported | 06/30/2026 | 1246979781 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $4,390.00 | 11/17/2025 | Non-covered Recipient Entity Kannar Eye Center | Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) | No dispute reported | 06/30/2026 | 1238522794 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $7,514.00 | 11/17/2025 | Non-covered Recipient Entity Kannar Eye Center | OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) | No dispute reported | 06/30/2026 | 1238522800 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $10,437.50 | 10/21/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Pilot clinical evaluation of investigational contact lenses | No dispute reported | 06/30/2026 | 1174888504 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $5,018.00 | 10/15/2025 | Non-covered Recipient Entity Kannar Eye Center | Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) | No dispute reported | 06/30/2026 | 1238522796 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $3,000.00 | 10/15/2025 | Non-covered Recipient Entity Kannar Eye Center | OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) | No dispute reported | 06/30/2026 | 1238522798 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $5,005.80 | 10/15/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522820 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $11,718.00 | 10/15/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522822 |
| Principal investigator 1 | TOPCON HEALTHCARE, INC. | $30,000.00 | 10/14/2025 | Non-covered Recipient Entity KANNARR EYE CARE | UTILIZATION OF TOPCON EQUIPMENT AND INTERATION TO IMPROVE MEDICAL KPI AND OFFICE EFFICIENCY | No dispute reported | 06/30/2026 | 1249770692 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $2,355.00 | 10/01/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of investigational contact lenses | No dispute reported | 06/30/2026 | 1174888476 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $14,025.00 | 09/30/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Evaluating myopia progression after discontinuation of a soft contact lens for myopia control. | No dispute reported | 06/30/2026 | 1174888415 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $3,262.00 | 09/30/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522790 |
| Principal investigator 1 | CooperVision Inc. | $7,400.00 | 09/16/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | CV-20-02 | No dispute reported | 06/30/2026 | 1243636043 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925499 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925501 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925503 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $29,600.00 | 08/22/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Pilot clinical evaluation of approved and investigational contact lenses | No dispute reported | 06/30/2026 | 1174888442 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $6,116.00 | 08/22/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522788 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925468 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925470 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925472 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925474 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925476 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925478 |
| Principal investigator 1 | Alcon Research LLC | $4,000.00 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925480 |
| Principal investigator 1 | Alcon Research LLC | $1,000.00 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925483 |
| Principal investigator 1 | Alcon Research LLC | $250.00 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925485 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925487 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925489 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925491 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925493 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925495 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 08/21/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925497 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $40,749.60 | 08/18/2025 | Non-covered Recipient Entity Kannarr Eye Care, LLC | A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness | No dispute reported | 06/30/2026 | 1246979778 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $9,959.40 | 08/14/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522816 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $7,430.40 | 08/14/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522818 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925376 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925378 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925380 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925382 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925384 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925386 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925388 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925390 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925392 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925394 |
| Principal investigator 1 | Alcon Research LLC | $673.83 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925396 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 08/07/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925398 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925360 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925362 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925364 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925366 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925368 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925370 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925372 |
| Principal investigator 1 | Alcon Research LLC | $512.54 | 07/31/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925374 |
| Principal investigator 1 | Alcon Research LLC | $1.00 | 07/30/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925166 |
| Principal investigator 1 | Alcon Research LLC | $6.00 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925168 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925170 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925172 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925174 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925176 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925178 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925180 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925182 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925184 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925186 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925188 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925190 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925192 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925194 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 07/24/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925350 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 07/24/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925352 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 07/24/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925354 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 07/24/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925356 |
| Principal investigator 1 | Alcon Research LLC | $620.94 | 07/24/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925358 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $3,858.00 | 07/23/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522786 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $4,000.00 | 07/21/2025 | Non-covered Recipient Entity Kannarr Eye Care, LLC | A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness | No dispute reported | 06/30/2026 | 1246979770 |
| Principal investigator 1 | Bausch & Lomb Americas Inc. | $35,084.00 | 07/21/2025 | Non-covered Recipient Entity Kannarr Eye Care, LLC | A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness | No dispute reported | 06/30/2026 | 1246979774 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 07/17/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925340 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 07/17/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925342 |
| Principal investigator 1 | Alcon Research LLC | $610.94 | 07/17/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925344 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 07/17/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925346 |
| Principal investigator 1 | Alcon Research LLC | $1,069.73 | 07/17/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925348 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925196 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925198 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925200 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925202 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925204 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925206 |
| Principal investigator 1 | Alcon Research LLC | $1.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925208 |
| Principal investigator 1 | Alcon Research LLC | $6.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925210 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925212 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925214 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925216 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925218 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925220 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925222 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925224 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925226 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925228 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925230 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925232 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925234 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925236 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925238 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925240 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925242 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925244 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925246 |
| Principal investigator 1 | Alcon Research LLC | $14.40 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925248 |
| Principal investigator 1 | Alcon Research LLC | $1.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925250 |
| Principal investigator 1 | Alcon Research LLC | $6.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925252 |
| Principal investigator 1 | Alcon Research LLC | $1.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925254 |
| Principal investigator 1 | Alcon Research LLC | $6.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925256 |
| Principal investigator 1 | Alcon Research LLC | $1.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925258 |
| Principal investigator 1 | Alcon Research LLC | $6.00 | 07/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925260 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $13,389.00 | 06/30/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Evaluating myopia progression after discontinuation of a soft contact lens for myopia control. | No dispute reported | 06/30/2026 | 1174888403 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $7,536.00 | 06/27/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of investigational contact lenses | No dispute reported | 06/30/2026 | 1174888465 |
| Principal investigator 1 | Alcon Research LLC | $4,000.00 | 06/26/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925464 |
| Principal investigator 1 | Alcon Research LLC | $1,000.00 | 06/26/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925466 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $5,866.00 | 06/23/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522778 |
| Principal investigator 1 | Alcon Research LLC | $16.20 | 06/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925505 |
| Principal investigator 1 | Alcon Research LLC | $6.00 | 06/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925507 |
| Principal investigator 1 | Alcon Research LLC | $1.00 | 06/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Evaluation of Soft Contact Lenses | No dispute reported | 06/30/2026 | 1220925509 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $6,336.00 | 06/13/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522812 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $7,162.00 | 06/10/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522784 |
| Principal investigator 1 | CooperVision Inc. | $2,500.00 | 05/28/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | CV-20-02 | No dispute reported | 06/30/2026 | 1243636039 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $8,964.00 | 05/09/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Pilot clinical evaluation of approved and investigational contact lenses | No dispute reported | 06/30/2026 | 1174888600 |
| Principal investigator 1 | Alcon Research LLC | $1,923.10 | 05/08/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925462 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $18,884.00 | 05/06/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522782 |
| Principal investigator 1 | Alcon Research LLC | $30.00 | 05/01/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses | No dispute reported | 06/30/2026 | 1220925460 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $5,012.00 | 05/01/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522776 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $4,489.20 | 04/28/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522810 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $10,137.60 | 04/28/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522814 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $18,169.00 | 04/14/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearNCT06749496 | No dispute reported | 06/30/2026 | 1174888588 |
| Principal investigator 1 | TOPCON HEALTHCARE, INC. | $15,000.00 | 04/11/2025 | Non-covered Recipient Entity KANNARR EYE CARE | UTILIZATION OF TOPCON EQUIPMENT AND INTERATION TO IMPROVE MEDICAL KPI AND OFFICE EFFICIENCY | No dispute reported | 06/30/2026 | 1249770690 |
| Principal investigator 1 | Alcon Research LLC | $2,831.15 | 04/10/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses | No dispute reported | 06/30/2026 | 1220925458 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $2,750.00 | 04/01/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of approved contact lenses | No dispute reported | 06/30/2026 | 1174888390 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $1,000.00 | 04/01/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of approved contact lenses | No dispute reported | 06/30/2026 | 1174888577 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $27,070.00 | 04/01/2025 | Non-covered Recipient Entity Kannar Eye Center | Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) | No dispute reported | 06/30/2026 | 1238522780 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $17,046.00 | 03/27/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Clinical evaluation of investigational contact lenses | No dispute reported | 06/30/2026 | 1174888523 |
| Principal investigator 1 | Sight Sciences, Inc. | $10,637.50 | 03/20/2025 | Non-covered Recipient Entity Kannarr Eye Care LLC | Prospective Randomized Masked Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease (SAHARA) | No dispute reported | 06/30/2026 | 1244586215 |
| Principal investigator 1 | Sight Sciences, Inc. | $8,547.30 | 03/20/2025 | Non-covered Recipient Entity Kannarr Eye Care LLC | Prospective Randomized Masked Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease (SAHARA) | No dispute reported | 06/30/2026 | 1244586219 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $14,313.60 | 03/19/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522808 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 02/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925448 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 02/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925450 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 02/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925452 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 02/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925454 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 02/20/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925456 |
| Principal investigator 1 | CooperVision Inc. | $3,100.00 | 02/17/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | CV-20-02 | No dispute reported | 06/30/2026 | 1243636053 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 02/13/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925446 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $15,550.20 | 02/10/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522806 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 02/06/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925412 |
| Principal investigator 1 | ABBVIE INC. | $7,793.00 | 02/04/2025 | Non-covered Recipient Entity KANNARR EYE CARE | M23-730 - A Multicenter, Double-masked, Randomized Study to Compare the Efficacy and Safety of the ABBV-444 Tear Formulation with REFRESH OPTIVE Unit Dose in Patients with Dry Eye Disease | No dispute reported | 06/30/2026 | 1202443795 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 01/30/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925430 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 01/30/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925438 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $36,762.75 | 01/27/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Pilot clinical evaluation of approved and investigational contact lenses | No dispute reported | 06/30/2026 | 1174888562 |
| Principal investigator 1 | Alcon Research LLC | $644.14 | 01/23/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925400 |
| Principal investigator 1 | Alcon Research LLC | $831.55 | 01/23/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925402 |
| Principal investigator 1 | Alcon Research LLC | $831.55 | 01/23/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925404 |
| Principal investigator 1 | Alcon Research LLC | $644.14 | 01/23/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925406 |
| Principal investigator 1 | Alcon Research LLC | $644.14 | 01/23/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925408 |
| Principal investigator 1 | Alcon Research LLC | $644.14 | 01/23/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925410 |
| Principal investigator 1 | Alcon Research LLC | $644.14 | 01/23/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925428 |
| Principal investigator 1 | Johnson & Johnson Vision Care, Inc. | $7,354.00 | 01/21/2025 | Non-covered Recipient Entity ADVANTAGE EYE CARE LLC | Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of WearNCT06749496 | No dispute reported | 06/30/2026 | 1174888491 |
| Principal investigator 1 | Oyster Point Pharma, Inc. | $11,664.00 | 01/17/2025 | Non-covered Recipient Entity Kannarr Eye Care | A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis | No dispute reported | 06/30/2026 | 1238522804 |
| Principal investigator 1 | Alcon Research LLC | $644.14 | 01/16/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925422 |
| Principal investigator 1 | Alcon Research LLC | $1,186.73 | 01/16/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses | No dispute reported | 06/30/2026 | 1220925424 |
| Principal investigator 1 | Alcon Research LLC | $831.55 | 01/16/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925426 |
| Principal investigator 1 | Alcon Research LLC | $831.55 | 01/16/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925432 |
| Principal investigator 1 | Alcon Research LLC | $831.55 | 01/16/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925434 |
| Principal investigator 1 | Alcon Research LLC | $1,186.73 | 01/16/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses | No dispute reported | 06/30/2026 | 1220925436 |
| Principal investigator 1 | Alcon Research LLC | $1,186.73 | 01/09/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses | No dispute reported | 06/30/2026 | 1220925414 |
| Principal investigator 1 | Alcon Research LLC | $831.55 | 01/09/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925416 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 01/09/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925418 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 01/09/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925420 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 01/09/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925440 |
| Principal investigator 1 | Alcon Research LLC | $1,053.83 | 01/09/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925442 |
| Principal investigator 1 | Alcon Research LLC | $644.14 | 01/09/2025 | Non-covered Recipient Entity KANNARR EYE CARE LLC | A Single-Arm Study to Evaluate and Demonstrate Safety and Performance of a Novel Ocular Lubricant in Adult Subjects with Dry Eye Disease | No dispute reported | 06/30/2026 | 1220925444 |